New COVID-19 Vaccine Trial in Sub-Saharan Africa: Ubuntu trial update

By Laia Ruiz Mingote

Banner

New COVID-19 Vaccine Trial in Sub-Saharan Africa: Ubuntu trial update
 
April 6, 2022 10 am ET/ 4 pm CEST/ 4 pm SAST.
 
Speaker
Nigel Garrett, MBBS MRCP MSc PhD. Head of the HIV Pathogenesis
and Vaccine Research programme at CAPRISA. Nigel is the CAPRISA
Investigator of Record for the HIV Vaccine Trials Network (HVTN) studies
and currently serves as international Co-chair on the COVPN 3008
Ubuntu mRNA vaccine trial, Co-PI on the Sisonke JnJ COVID-19 vaccine
study and PI on several NIH self-initiated grants. As Principal and Co-
Investigator, he has conducted more than 20 randomized clinical trials
and large cohort studies related to HIV prevention and COVID-19
vaccines and has published more than 100 manuscripts on topics
including vaccines, HIV prevention and sexual health.
 
Moderator
Ntando Yola, Co-founder and Managing Director of Community
Mobilization and Engagement with Advocates for the Prevention of HIV in
Africa (APHA), education officer with the Desmond Tutu HIV Foundation
(DTHF) in Cape Town, South Africa and HPTN Community Working
Group Co-Chair.
 
Register at the link
 

Share this story:

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn